CSIR touts dubious 'Ayurveda' product for diabetes
At 6 am on September 13, the CSIR handle on X.com published the following post about an "anti-diabetic medicine" called either "Daiba 250" or "Diabe 250", developed at th…
Ministry of AYUSH
3 posts
On the Nature feature about the Sarafs, a rare disease, and time
Heidi Ledford has a tragic and powerful story published yesterday in Nature, about a team of scientists at the CSIR-Institute of Genomics and Integrative Biology racing to develop a CRISPR treatment f…
Government by Supreme Court
On February 27, a bench of the Supreme Court upbraided Patanjali Ayurved and its chairman Acharya Balkrishna for continuing to disparage systems of medicine other than Ayurveda (technically, what it c…